Profilo
La signora Anila Lingamneni è Chief Technology Officer & Executive VP presso Haemonetics Corp. La sig.ra Lingamneni è stata precedentemente impiegata come vicepresidente di ricerca e sviluppo renale presso Baxter International, Inc. e come responsabile della tecnologia-X-Ray Diagnostic Imaging presso GE Healthcare, Inc. Si è laureata al Birla Institute of Technology & Science, si è laureata al Birla Institute of Technology & Science e si è laureata alla Iowa State University.
Precedenti posizioni note di Anila Lingamneni
| Società | Posizione | Fine |
|---|---|---|
| HAEMONETICS CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/11/2024 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/03/2020 |
GE Healthcare, Inc.
GE Healthcare, Inc. Medical SpecialtiesHealth Technology Manufactures and retails diagnostic imaging & medical equipment | Corporate Officer/Principal | - |
Formazione di Anila Lingamneni
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Haemonetics Corp.
Haemonetics Corp. Medical SpecialtiesHealth Technology Designs, manufactures, markets and services blood processing systems | Health Technology |
Birla Institute of Technology & Science
Birla Institute of Technology & Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iowa State University
Iowa State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GE Healthcare, Inc.
GE Healthcare, Inc. Medical SpecialtiesHealth Technology Manufactures and retails diagnostic imaging & medical equipment | Health Technology |
















